What happens when you take carbamazepine with st. john's wort?
Carbamazepine (brand names Tegretol, Carbatrol, Equetro, and others) is a workhorse anticonvulsant also used for trigeminal neuralgia and as a mood stabilizer in bipolar disorder. It is metabolized primarily by the liver enzyme CYP3A4, and it has the unusual property of inducing its own metabolism over the first few weeks of treatment, a phenomenon called autoinduction. Once autoinduction is complete, the maintenance dose is typically higher than the starting dose.
St. John's Wort is a potent inducer of CYP3A4 through its activation of the pregnane X receptor. On paper, you would predict that St. John's Wort would dramatically lower carbamazepine levels. In practice, the picture is more nuanced. A small healthy-volunteer study found that adding St. John's Wort to chronic carbamazepine did not further reduce carbamazepine levels, presumably because carbamazepine had already maximally induced its own metabolism. Another study, however, found that St. John's Wort reduced exposure to single carbamazepine doses by about 21% before autoinduction had set in.
What this means in real life: the effect is unpredictable. It depends on whether autoinduction is fully established, the specific hyperforin content of the herbal product, individual genetics, and concurrent medications. The interaction may also matter most at transitions: starting carbamazepine, restarting after a break, stopping St. John's Wort, or any dose change.
Why is this important?
Carbamazepine has a relatively narrow therapeutic window. Low levels mean breakthrough seizures, mood instability, or return of trigeminal neuralgia pain. High levels mean dizziness, double vision, ataxia, drowsiness, hyponatremia, and rarely serious adverse effects like aplastic anemia or Stevens-Johnson syndrome (which can be more likely in HLA-B*1502 carriers).
The most dangerous moment is when someone stops St. John's Wort while continuing carbamazepine. Loss of enzyme induction over a week or two lets carbamazepine clearance fall, plasma concentrations rise, and previously stable patients become toxic. Conversely, starting St. John's Wort in a carbamazepine-naive patient or one who has not yet fully autoinduced can drop carbamazepine exposure enough to risk loss of seizure or mood control.
From a regulatory standpoint, both Health Canada and the European Medicines Agency, along with many national agencies, list St. John's Wort as a contraindicated or cautionary combination with anticonvulsants, including carbamazepine.
There is also the issue of St. John's Wort's main labeled use: depression. People with epilepsy have higher-than-average rates of depression. People on carbamazepine for bipolar disorder are even more likely to look for additional mood support. So the at-risk population for this combination is larger than it might seem.
What should you do?
If you take carbamazepine for any indication, do not start St. John's Wort. The unpredictability of the interaction makes safe co-administration impractical.
If you are already taking both and want to discontinue the herb, do it under medical supervision. Ask your prescriber about a baseline carbamazepine level, then a follow-up level 1-2 weeks after stopping St. John's Wort. Be alert to dizziness, blurry or double vision, unsteadiness, or unusual drowsiness, which can be early signs that your carbamazepine concentration has climbed too high.
If your reason for considering St. John's Wort is mild to moderate depression, talk to your prescriber about safer evidence-based options. Several SSRIs are used alongside carbamazepine, though carbamazepine's enzyme induction can lower antidepressant exposure, so dose adjustments may be needed. Cognitive behavioral therapy and lifestyle changes are also reasonable first-line steps.
Pregnancy and contraception adds another layer. Carbamazepine already lowers the effectiveness of hormonal contraceptives via the same CYP3A4 pathway, and St. John's Wort compounds that risk. Anyone on carbamazepine who could become pregnant should be using a contraceptive method that does not depend on CYP3A4-vulnerable hormones.
Which specific products are affected?
On the medication side, the interaction applies to all formulations of carbamazepine, including:
- Tegretol (immediate-release tablets and suspension)
- Tegretol XR (extended-release)
- Carbatrol and Equetro (extended-release capsules)
- Generic carbamazepine immediate- and extended-release products
The closely related drug oxcarbazepine (Trileptal) shares some metabolic pathways with carbamazepine but is primarily handled by different enzymes; the St. John's Wort interaction with oxcarbazepine is less well characterized but still considered a caution.
On the supplement side, the concern covers essentially all hyperforin-containing St. John's Wort products:
- Standardized Hypericum perforatum capsules and tablets
- St. John's Wort teas and tinctures
- Combination herbal "mood" or "calm" blends
The bottom line
St. John's Wort plus carbamazepine is unpredictable in a way that biases toward harm. The herb can drop carbamazepine levels in patients who have not yet autoinduced, and stopping the herb later can let levels surge into the toxic range. There are safer ways to treat depression in someone taking carbamazepine. Talk to your prescriber rather than self-treating with an herbal product that has more interaction risk than most prescription drugs.